Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gagel

Showing results (191-200 of 330) with videos related to

Pageof 33
Sort By:
Surgery|December 17, 1998
Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomasJ E Lee, D B Evans, R C Hickey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumorsVali Papadimitrakopoulou, Sofia Agelaki, Hai T Tran, et al.
The New England Journal of Medicine|February 25, 1988
The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experienceR F Gagel, A H Tashjian, T Cummings, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2005
Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II studyMichael Pinkawa, Karin Fischedick, Peter Treusacher, et al.
Henry Ford Hospital Medical Journal|January 1, 1989
Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: a new variantD T Donovan, M L Levy, E J Furst, et al.
Endocrine-Related Cancer|May 29, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Early thyroidectomy in multiple endocrine neoplasia: a four decade experienceElizabeth G Grubbs, Ronald M Lechan, Beth Edeiken-Monroe, et al.
The American Journal of Pathology|April 1, 1976
Adrenal medullary hyperplasia. A morphometric analysis in patients with familial medullary thyroid carcinomaR A DeLellis, H J Wolfe, R F Gagel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 26, 2009
Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysisMichael Pinkawa, Marc D Piroth, Branka Asadpour, et al.
Thyroid : Official Journal of the American Thyroid Association|July 25, 2008
Four patients with cutaneous metastases from medullary thyroid cancerLibero Santarpia, Adel K El-Naggar, Steven I Sherman, et al.
BMC Cancer|August 26, 2009
Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatmentMichael Pinkawa, Karin Fischedick, Bernd Gagel, et al.
Pageof 33

Showing results (191-200 of 330) with videos related to

Sort By:
Pageof 33
Surgery|December 17, 1998
Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomasJ E Lee, D B Evans, R C Hickey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumorsVali Papadimitrakopoulou, Sofia Agelaki, Hai T Tran, et al.
The New England Journal of Medicine|February 25, 1988
The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experienceR F Gagel, A H Tashjian, T Cummings, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2005
Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II studyMichael Pinkawa, Karin Fischedick, Peter Treusacher, et al.
Henry Ford Hospital Medical Journal|January 1, 1989
Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: a new variantD T Donovan, M L Levy, E J Furst, et al.
Endocrine-Related Cancer|May 29, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Early thyroidectomy in multiple endocrine neoplasia: a four decade experienceElizabeth G Grubbs, Ronald M Lechan, Beth Edeiken-Monroe, et al.
The American Journal of Pathology|April 1, 1976
Adrenal medullary hyperplasia. A morphometric analysis in patients with familial medullary thyroid carcinomaR A DeLellis, H J Wolfe, R F Gagel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 26, 2009
Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysisMichael Pinkawa, Marc D Piroth, Branka Asadpour, et al.
Thyroid : Official Journal of the American Thyroid Association|July 25, 2008
Four patients with cutaneous metastases from medullary thyroid cancerLibero Santarpia, Adel K El-Naggar, Steven I Sherman, et al.
BMC Cancer|August 26, 2009
Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatmentMichael Pinkawa, Karin Fischedick, Bernd Gagel, et al.
Pageof 33